Clinical Trial Update: A Study of ILB2109 in Patients With Advanced Solid Malignancies [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study of ILB2109 in patients with advanced solid malignancies. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• ILB2109

Snippet

Sponsor: Innolake Biopharm | Conditions: Advanced Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING